Clinical Trials Logo

Stomach Neoplasm clinical trials

View clinical trials related to Stomach Neoplasm.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05971069 Completed - Stomach Neoplasm Clinical Trials

Real-time Identification of the Aberrant Left Hepatic Arterial Territory in the Liver Using Near-infrared Fluorescence Imaging

Start date: December 17, 2021
Phase: N/A
Study type: Interventional

" Hepatic artery variants are occasionally seen, especially 20-30% of aberrant left hepatic artery. In radical gastrectomy, decision for aberrant left hepatic artery(ALHA) ligation should consider the oncologic safety and liver-related complication. Theoretically, the ALHA preservation is the most ideal in the aspect of liver function protection. However, it is technically difficult which consumes much time. Not only that, oncologic safety could be threatened as some soft tissues, including lymph nodes, could be remained while in preserving the ALHA. There has been no standardized method to evaluate the ALHA, and to decide whether preserve or ligate it. This prospective study has been designed to develop the decision algorithm to define the ALHA preservation/ligation, using near-infrared fluorescence imaging during surgery. "

NCT ID: NCT05714878 Completed - Stomach Neoplasm Clinical Trials

Multimodal Prehabilitation for Resectable Gastric Cancer

Start date: March 22, 2023
Phase: N/A
Study type: Interventional

Surgical resection is the mainstay for gastric cancer. Surgical stress response, like insulin resistance and catabolism, is inevitable and is a risk factor for postoperative outcome. To cope with this stress, the enhanced recovery protocol has been proposed and successfully implemented in clinical practice. Recently, prehabilitation have attracted increasingly attention, which is the preoperative part of enhanced recovery pathway. Prehabtilitation are bundles of evidenced elements in order to improve patient's functional capacity. Patients with gastric cancer are usually suffered from nutritional risk, anxiety and frailty. In this trial, we investigate whether multimodal prehabilitation (exercise, nutrition and psychological support) could improve patient's functional status to better tolerate surgical trauma.

NCT ID: NCT04889859 Completed - Clinical trials for Diabetes Mellitus, Type 2

Impact of Biliopancreatic Limb Length on Diabetes Following Distal Gastrectomy

Start date: May 1, 2019
Phase: N/A
Study type: Interventional

This is a prospective, randomized controlled trial to investigate the impact of a long biliopancreatic limb of Roux-en-Y reconstruction on diabetes control in patients with concurrent type 2 diabetes and gastric cancer

NCT ID: NCT04466592 Completed - Clinical trials for Esophageal Neoplasms

Health and Employment After Gastro Intestinal Surgery - HEAGIS1

HEAGIS1
Start date: December 13, 2019
Phase: N/A
Study type: Interventional

By using the M.A.D.I.T. methodology and the Dialogics science, SALVO Project aims to develop operational guidelines to support oncological target patients in the resumption of their daily post-operative activities. The research will implement an instrument for the purpose of measuring the health need of participants who are admitted to the surgical ward. Therefore, targeted interventions will be implemented with participants, and efficacy will be evaluated in order to define treatment guidelines. The principal aim of this study is to create a validated and replicable intervention model for supporting patients who undergone surgery for esophagus and gastro intestinal cancer.

NCT ID: NCT04329299 Completed - Stomach Neoplasm Clinical Trials

Use of Blood Biomarkers to Predict Gastric Cancer Risk

Start date: December 3, 2012
Phase:
Study type: Observational

This study aims to develop a cost-effective screening strategy for the Singapore population by targeted screening of people who have a high risk of stomach cancer, in order to detect early signs of the disease at a stage that can be prevented or cured. Often, patients only consult their doctors when they have advanced symptoms, by which time the cancer may be at a difficult to treat, or incurable stage. Using costs in the Singapore health system as well as local population risk profiles and demographics, our previous study demonstrated that screening of high-risk groups is cost-effective and a panel of serum makers was effective in differentiating high-risk from low-risk individuals. This study aims to validate the predictive value of various blood biomarkers, such as that of antibodies against Helicobacter pylori, pepsinogen levels, micro RNAs (miRNAs) and blood-based protein markers in participants who have been scheduled to undergo upper gastrointestinal (GI) endoscopy for clinical reasons. If successful, the marker can be used to stratify population into different risk groups and various screening systems can be provided according to different risk level. This will reduce the number of annual invasive screening examinations required to detect early gastric cancer (GC), thereby rendering it cost-effective to generalize as clinical practice in Singapore.

NCT ID: NCT03880747 Completed - Stomach Neoplasm Clinical Trials

Dumping Syndrome and Quality of Life After Vagus Nerve-preserving Distal Gastrectomy

VNP
Start date: August 9, 2017
Phase:
Study type: Observational

There is no consensus on what type of function-preserving gastrectomy can provide the best patient quality of life (QOL). This study aims to evaluate the incidence of dumping syndrome after vagus nerve-preserving distal gastrectomy (VPNDG).

NCT ID: NCT03549494 Completed - Clinical trials for Head and Neck Neoplasms

Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction

Start date: October 25, 2018
Phase: Phase 2
Study type: Interventional

Our main objective is to evaluate the effect of Ocoxin-Viusid on the quality of life of patients with advanced stomach cancer and esophagogastric junction. The Ocoxin-Viusid nutritional supplement is expected to improve quality of life and tolerance to treatment with Chemotherapy.

NCT ID: NCT03313700 Completed - Stomach Neoplasm Clinical Trials

Clinical Outcomes of Robotic Versus Laparoscopic Distal Gastrectomy for Gastric Cancer

RDG
Start date: September 25, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to explore the clinical outcomes of the robotic distal gastrectomy for patients with gastric adenocarcinoma(cT1-4a, N-/+, M0).

NCT ID: NCT03071237 Completed - Stomach Neoplasm Clinical Trials

The Origin of Infrapyloric Artery

IPA-Origin
Start date: March 4, 2017
Phase:
Study type: Observational

Infrapyloric artery(IPA) is of great importance for gastric cancer patients. According to previous study, the origin of IPA varies greatly among different studies. This trial aims to tell the distribution of IPA origin in Chinese patients.

NCT ID: NCT02527785 Completed - Stomach Neoplasm Clinical Trials

Study of Oxaliplatin, Irinotecan, and S-1 in Gastric Cancer

Start date: February 2015
Phase: Phase 2
Study type: Interventional

This study will conduct a phase II study of triple combination with oxaliplatin, irinotecan, and S-1 as the first-line chemotherapy in patients with advanced gastric cancer.